Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9855119rdf:typepubmed:Citationlld:pubmed
pubmed-article:9855119lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0085149lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0677043lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0522536lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:9855119lifeskim:mentionsumls-concept:C0729218lld:lifeskim
pubmed-article:9855119pubmed:issue6lld:pubmed
pubmed-article:9855119pubmed:dateCreated1999-2-17lld:pubmed
pubmed-article:9855119pubmed:abstractTextWe clinically and pathologically analyzed renal allografts from 1 9 renal transplant patients treated with tacrolimus (FK506) for more than 1 year.lld:pubmed
pubmed-article:9855119pubmed:languageenglld:pubmed
pubmed-article:9855119pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855119pubmed:citationSubsetIMlld:pubmed
pubmed-article:9855119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9855119pubmed:statusMEDLINElld:pubmed
pubmed-article:9855119pubmed:monthNovlld:pubmed
pubmed-article:9855119pubmed:issn0919-8172lld:pubmed
pubmed-article:9855119pubmed:authorpubmed-author:OkuyamaAAlld:pubmed
pubmed-article:9855119pubmed:authorpubmed-author:NaganoSSlld:pubmed
pubmed-article:9855119pubmed:authorpubmed-author:HatoriMMlld:pubmed
pubmed-article:9855119pubmed:authorpubmed-author:TakaharaSSlld:pubmed
pubmed-article:9855119pubmed:authorpubmed-author:KokadoYYlld:pubmed
pubmed-article:9855119pubmed:authorpubmed-author:KyoMMlld:pubmed
pubmed-article:9855119pubmed:issnTypePrintlld:pubmed
pubmed-article:9855119pubmed:volume5lld:pubmed
pubmed-article:9855119pubmed:ownerNLMlld:pubmed
pubmed-article:9855119pubmed:authorsCompleteYlld:pubmed
pubmed-article:9855119pubmed:pagination526-33lld:pubmed
pubmed-article:9855119pubmed:dateRevised2006-10-30lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:meshHeadingpubmed-meshheading:9855119-...lld:pubmed
pubmed-article:9855119pubmed:year1998lld:pubmed
pubmed-article:9855119pubmed:articleTitleClinical and histopathologic examination of renal allografts treated with tacrolimus (FK506) for at least one year.lld:pubmed
pubmed-article:9855119pubmed:affiliationDepartment of Urology, Osaka University School of Medicine, Japan.lld:pubmed
pubmed-article:9855119pubmed:publicationTypeJournal Articlelld:pubmed